date,title,source
Nov-01-18,Nabriva files new drug application with FDA for urinary tract infection drug,American City Business Journals
Nov-01-18,Nabriva Therapeutics Completes Submission of New Drug Application to U.S. Food and Drug Administration for Intravenous CONTEPO to Treat Complicated Urinary Tract Infections,GlobeNewswire
Nov-06-18,Nabriva Therapeutics Reports Third Quarter 2018 Financial Results and Recent Corporate Highlights,GlobeNewswire
